Newsfile Corp
29 Jun 2026, 20:02 UTC · 18w ago
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Impact · against what's priced in
ADMA Biologics faces significant downside risk following allegations of channel stuffing and internal control failures, which threaten the integrity of its reported revenue. While other companies like Zillow, Wix, and Via are also mentioned in the context of legal notices, the primary catalyst here is the severe accounting red flag associated with ADMA.
- VIA−0.40
No priced-in read yet





